Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Psychotropic drug interactions with valproate.

Jessica Fleming1, Manoranjenni Chetty

  • 1Faculty of Pharmacy, University of Sydney, Sydney, NSW 2006, Australia. jfle7329@mail.usyd.edu.au

Clinical Neuropharmacology
|March 30, 2005
PubMed
Summary

Valproate, an anticonvulsant, interacts with many psychotropic drugs due to its metabolism and enzyme inhibition. Understanding these pharmacokinetic interactions is crucial for safe and effective patient treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using participatory epidemiology to understand differences in tick-borne disease perceptions from homeowners in the Ohio River valley.

One health (Amsterdam, Netherlands)·2026
Same author

Medical and veterinary pathogens detected in invading Asian longhorned ticks (Haemaphysalis longicornis) from Ohio and Pennsylvania.

American journal of veterinary research·2025
Same author

Proteomic Analysis of Spatial Heterogeneity Identifies HMGB2 as Putative Biomarker of Tumor Progression in Adult-Type Diffuse Astrocytomas.

Cancers·2024
Same author

A Review of Hodgkin Lymphoma in the Era of Checkpoint Inhibitors.

Cureus·2023
Same author

Design and conduct considerations for studies in patients with hepatic impairment.

Clinical and translational science·2022
Same author

Magnetic sensitivity of cryptochrome 4 from a migratory songbird.

Nature·2021

Area of Science:

  • Pharmacology
  • Neuroscience
  • Clinical Pharmacy

Background:

  • Valproate is a widely used anticonvulsant with mood-stabilizing properties.
  • It is frequently prescribed with other psychotropic medications.
  • Valproate possesses complex pharmacokinetic and pharmacodynamic properties.

Purpose of the Study:

  • To provide an overview of pharmacokinetic interactions between valproate and psychotropic medications.
  • To focus on the mechanisms underlying these drug interactions.
  • To discuss the potential clinical consequences of these interactions.

Main Methods:

  • Review of existing literature on valproate drug interactions.
  • Analysis of valproate's metabolic pathways (conjugation, beta-oxidation, CYP450 oxidation).

Related Experiment Videos

  • Examination of valproate's inhibitory effects on hepatic enzymes (glucuronosyltransferase, epoxide hydrolase, CYP2C enzymes).
  • Consideration of valproate's saturable protein binding and competitive displacement.

    • Main Results:

    • Valproate is metabolized via multiple pathways and inhibits various hepatic enzymes.
    • It exhibits saturable protein binding, leading to competition with other drugs.
    • Numerous pharmacokinetic interactions between valproate and psychotropic drugs have been documented across all classes.

    Conclusions:

    • Valproate's pharmacokinetic profile predisposes it to significant interactions with psychotropic agents.
    • Understanding these interactions is essential for optimizing therapeutic outcomes and minimizing adverse effects.
    • Further research into specific drug-drug interactions and their clinical impact is warranted.